BioNTech SE - ADR

NASDAQ:BNTX   3:59:50 PM EDT
104.93
+3.06 (+3.00%)
5:07:19 PM EDT: $104.95 +0.02 (+0.02%)
Products

Pfizer And BioNTech To Submit Emergency Use Authorization Request Today To The U.S. FDA For COVID-19 Vaccine

Published: 11/20/2020 12:42 GMT
BioNTech SE (BNTX) - Pfizer and Biontech to Submit Emergency Use Authorization Request Today to the U.S. FDA for Covid-19 Vaccine.
Pfizer and Biontech to Submit Emergency Use Authorization Request Today to the U.S. FDA for Covid-19 Vaccine.
Pfizer Inc - Bnt162b2 Demonstrated a Vaccine Efficacy Rate of 95%, With No Serious Safety Concerns Observed to Date.
Pfizer Inc - Companies Expect to Produce Globally Up to 50 Million Doses in 2020 and Up to 1.3 Billion Doses by End of 2021.
Pfizer Inc - Companies Will Be Ready to Distribute Vaccine Within Hours After Authorization.
Pfizer Inc - to Date, Data Monitoring Committee (dmc) for Study Has Not Reported Any Serious Safety Concerns Related to Vaccine.